Signal-driven regulatory intelligence, not PDF forwards.
Automated tracking of FDA, EMA, ICH, MHRA, PMDA and CDSCO publications, tuned to your therapeutic area and product portfolio.
Regulatory intelligence is the systematic monitoring of regulations, guidance, consultations and enforcement actions relevant to your products and markets, turned into decisions rather than a reading list. Its value is in noticing that something has changed status — a draft annex adopted, a guidance finalised — before it changes what your evidence has to show.
Outcomes you can expect
- Curated regulatory feed
- Impact assessment
- Actionable digest
Regulatory Intelligence is delivered by our regulatory services practice. Where it saves time, the team uses our products: GxP Copilot for validation lifecycle work and TraceDraft for clinical documentation.
Explore related capabilities: Regulatory Compliance, Regulatory Information Management (RIM), eQMS Implementation & Validation, Pharmacovigilance.
What Regulatory Intelligence Should Deliver
Most regulatory intelligence programmes deliver information — a feed of regulatory publications, guidance documents, and agency announcements forwarded to the regulatory affairs team. The problem is not the quantity of information: it is the absence of signal filtering, impact assessment, and actionable prioritisation that transforms information into intelligence. A pharmaceutical regulatory affairs team does not need to know about every FDA guidance published in a month — it needs to know which of those guidance documents is relevant to its product portfolio, what the guidance requires, when the compliance deadline is, and what action it implies.
Cybroscape's regulatory intelligence service provides this signal-to-action chain. We maintain automated tracking of FDA, EMA, ICH, MHRA, PMDA, and CDSCO publication feeds, filtered against the organisation's therapeutic area and product portfolio profile. Each flagged publication receives an impact assessment that answers: is this relevant to our products? What does it require? When does compliance apply? What is the recommended response? High-urgency items — guidance with imminent compliance deadlines, PRAC safety signals, IND-affecting changes — receive priority alerts within 48 hours of publication.
Building the Regulatory Intelligence Function Internally
Regulatory intelligence is most valuable when it is embedded in the organisation's strategic planning cycle — when it informs CMC strategy, clinical programme design, and portfolio decisions rather than arriving as a compliance obligation after the fact. Building this function internally requires both a systematic process for monitoring and filtering regulatory publications and the regulatory expertise to interpret their implications correctly.
For organisations building their regulatory intelligence function, we provide a programme design service that includes: source inventory and monitoring automation design; filtration logic development aligned to the therapeutic area and product portfolio; impact assessment template development; and integration with the organisation's submission and CMC planning calendar so that regulatory intelligence inputs arrive at the right planning decision points. We can also provide the ongoing intelligence monitoring service under a managed services contract for organisations that want to maintain the internal strategic value of regulatory intelligence without the overhead of running the monitoring function.
See it on your own system.
Bring a URS or a system. We show you the validation package it produces.
- We reply within one business day
- We run your URS live on the call
- You get a clear plan and scope